Inventor · disambiguated record
Jianyu Lu
Also filed as: LU JIANYU
8 granted patents·1 pending application·8 citations·filing 2017–2021
77Inventor score
Files withLUOXIN PHARMACEUTICAL SHANGHAI CO LTD4CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD2GENFLEET THERAPEUTICS SHANGHAI INC2MEDSHINE DISCOVERY INC1
Top patents by PatentIndex Score
9 records- 0177US11034653B2Crystal form of estrogen receptor inhibitor and preparation method thereforLUOXIN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2018·Granted Jun 15, 2021·2 cites·12 claims
- 0276US11691974B23,9-diazaspiro[5,5]undecane compound as FLT3 and AXL inhibitorsMEDSHINE DISCOVERY INC·Filed 2019·Granted Jul 4, 2023·1 cites·7 claims
- 0376US10548883B2Benzotriazole-derived α and β-unsaturated amide compound used as TGF-β RI inhibitorGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2017·Granted Feb 4, 2020·1 cites·19 claims
- 0476US10519143B2Substituted-indole-compounds as estrogen receptor down-regulatorsLUOXIN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2017·Granted Dec 31, 2019·3 cites·25 claims
- 0572US12221432B2Estrogen receptor antagonistCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2019·Granted Feb 11, 2025·1 cites·20 claims
- 0662US12098127B2Salt form of estrogen receptor downregulator, crystalline form thereof, and preparation method thereforLUOXIN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2019·Granted Sep 24, 2024·0 cites·10 claims
- 0755US2024043401A1Salt form of tetra-substituted olefin compound, crystal, and preparation method thereforCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2021·Application pending·0 cites
- 0849US11236112B2Crystal form and salt form of TGF-βRI inhibitor and preparation method thereforGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2018·Granted Feb 1, 2022·0 cites·16 claims
- 0947US10774081B2Indolo substituted piperidine compound as estrogen receptor down-regulatorLUOXIN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2017·Granted Sep 15, 2020·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Jianyu Lu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →